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ABSTRACT  
Objective: To evaluate the hypoglycemic activity of Boswellia carterii and Cissus rotundifolia in rats compared to that 
of glibenclamide and metformin as common oral hypoglycemic drugs. 
Methods: Thirty-six male Wistar rats, divided into six groups of six rats each, were assigned into diabetic and non-
diabetic groups. Diabetes was induced in rats by single intraperitoneal administration of streptozotocin (65 mg/kg 
b.w.) and nicotinamide (110 mg/kg b.w.). The first two groups were normal and diabetic controls, whereas the other 
four diabetic groups were treated with water extracts of the medicinal plants; B. carterii (100 mg/kg b.w.) and C. ro-
tundifolia (100 mg/kg b.w.), glibenclamide (5 mg/kg b.w.) and metformin (150 mg/kg b.w.). Body weight and serum 
glucose were measured on days 1, 7, 14, 21 and 28. Serum cholesterol and triglyceride levels were also measured. 
Results: Treatment of diabetic rats with the water extracts of B. carterii and C. rotundifolia for four weeks resulted in a 
significant (p<0.05) increase in their body weights and a significant decrease in the levels of serum glucose, cholester-
ol and triglycerides. The effects of the two plant extracts were almost similar to those of glibenclamide and metformin.  
Conclusion: Water extracts of B. carterii or C. rotundifolia have a hypoglycemic effect resembling those of 
glibenclamide and metformin, and these findings provide a pharmacological evidence for their anti-diabetic claims in 
folk medicine. 
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1. Introduction 
Diabetes mellitus (DM) is a common metabolic 
disease that affects the people of both devel-
oped and developing countries (1). According 
to the International Diabetes Federation (IDF), 
it is estimated that 230 million people in the 
world have diabetes. Additionally, the World 
Health Organization (WHO) estimates that this 
number will exceed 370 million by 2030 and 
considers the disease as the fifth leading cause 
of death in the world (1). DM may be caused by 
the abnormality of carbohydrate metabolism 
that is linked to low blood insulin level or in-
sensitivity of target organs to insulin, leading to 
hyperglycemia (2).  
Chronic hyperglycemia in diabetic patients 
leads to severe damage in body tissues, organ 
dysfunctions and finally irreversible failure of 
some vital organs, especially the eyes, kidneys, 
heart and blood vessels (3). DM is associated 
with many complications such as blindness, re-
nal failure, cardiovascular diseases and limb 
amputations (2). Furthermore, it could be ac-
companied by dyslipidemia that may lead to 
cardiovascular disorders, which are major 
causes of morbidity and mortality among dia-
betic patients (3). 
The pernicious effects of DM are mediated 
by the oxidative stress that is associated with 
high production of reactive oxygen species 
(ROS) and impaired antioxidant defense sys-
tems, which cause lipid peroxidation, alteration 
in antioxidant enzymes and impaired glutathi-
one metabolism (4).  
Streptozotocin (STZ) is a toxic chemical to 
pancreatic β‐cells that induces their rapid and 
irreversible necrosis. The resulted glucose au-
to-oxidation leads to extreme formation of free 
radicals in DM, disrupting the cell membrane 
functions and enhancing susceptibility to lipid 
peroxidation (5). Previous studies reported dif-
ferences in the type and characteristics of diabe-
tes according to the administered doses of STZ 
and nicotinamide (NA) as well as the experi-
mental animal species used (6). NA was used in 
this study for its protective effect on β-cells 
against the diabetogenic effect of STZ and this 
may be due, in part, to an increase in the pool 
size of nicotinamide adenine dinucleotide in 
pancreatic β‐cells, that leads to the partial de-
struction of these cells and the induction of type-
2 DM (6). 
Globally, DM has shadowed the spread of 
modern lifestyle and can be linked to an increas-
ingly overweight and sedentary population, 
where about 90% of the cases are of the type-2 
DM, paralleling the incidence of obesity (2). For 
people with type-1 DM, insulin replacement 
therapy from exogenous sources is necessary for 
saving lives (7). Although lifestyle modification 
is the first-line approach for early-stage diabetic 
patients, chemotherapeutic treatment of type-2 
DM remains the major approach to successfully 
control hyperglycemia (8). Nevertheless, oral 
hypoglycemic drugs have prominent side effects 
and fail to significantly alter the course of dia-
betic complications (9). 
Oral hypoglycemic drugs can act in various 
ways such as enhancing of pancreatic β-cells to 
release insulin, resisting glucose-increasing 
hormones, increasing the number and sensitivi-
ty of insulin receptors, increasing glycogenesis 
and promoting the tissue use of glucose (10). 
Other activities of these drugs include scaveng-
ing of free radicals, correcting the metabolic dis-
orders of lipids and proteins and enhancing the 
microcirculation of the body (11). Most glucose-
lowering drugs have side effects, including se-
vere hypoglycemia, lactic acidosis, idiosyncratic 
liver cell injury, permanent neurological deficit, 
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digestive discomfort, headache and dizziness 
(12). The sulfonylureas and biguanides are the 
traditional treatment groups of choice for type-
2 DM (7). 
The WHO estimate that about 80% of the 
populations living in the developing countries 
rely almost exclusively on traditional medicine 
for their primary health cares (13, 14). Howev-
er, only a minority of traditionally used medici-
nal plants have been evaluated for their chemi-
cal and pharmacological properties (15).  
Boswellia carterii (Family: Burseraceae), 
commonly called olibanum, is one of the oldest 
aromatic materials used by mankind. It has 
been mainly used in traditional Chinese medi-
cine to alleviate pain and inflammation (16). 
The extract of B. carterii contains potentially ac-
tive triterpene acids such as boswellic acids and 
incensole acetate (17). The plant resin has been 
used for treating ulcerative colitis, chronic coli-
tis, Crohn's disease and osteoarthritis due to its 
anti-inflammatory effects. In the folk medicine, 
B. carterii resin is prescribed either alone or in 
combination with other plants for diabetic pa-
tients (18). Historically, it has been used as in-
cense in religious and cultural ceremonies, and 
it is now widely used as an adhesive agent and 
as an ingredient in cosmetic preparations (19).  
Cissus rotundifolia is a climbing or prostrate 
shrub found throughout Africa, Egypt and the 
Arabian Peninsula, being used as a vegetable. It 
has minor economic importance as a medicinal 
plant (20, 21, 22). C. rotundifolia from Asia and 
Africa has shown anti-diabetic as well as anti-
parasitic properties (23, 24). In Yemen, the 
boiled leaves of C. rotundifolia are eaten with 
meals as an appetizer and are also used as an 
antipyretic in the treatment of malaria and 
dengue fever (25). The present study aimed to 
evaluate the hypoglycemic activity of B. carterii 
and C. rotundifolia in rats compared to 
glibenclamide and metformin. 
2. Methods 
The experimental protocol of the present study 
was approved by the Ethics Committee of the 
University of Science and Technology, Sana'a, 
Yemen. 
2.1. Materials and experimental animals 
STZ and NA were bought from Sigma-Aldrich 
Corporation (Germany), whereas Glibenclamide 
(Daonil®) and metformin (Glucophage®) were 
obtained from pharmacies in Sana'a, Yemen. Kits 
for the measurement of glucose, cholesterol and 
triglycerides (Química Clínica Aplicada S.A., Am-
posta, Spain) were bought from the local market. 
B. carterii resin and C. rotundifolia leaves were 
brought from the local market and identified in 
Aden University. 
Thirty-six adult male Wistar rats (Rattus 
norvegicus) weighing between 240 and 300 g 
were brought from the Animal House of the Fac-
ulty of Science, Sana'a University. Rats were 
housed in well-ventilated cages (six rats each) 
and acclimatized to the laboratory conditions 
(12:12 h light/dark schedule with 25±2°C and 
55–65% relative humidity). The rats were fed 
with the same food and water ad libitum. 
2.2. Preparation of water extract of the plant 
species 
Fifty grams of the dry resin of B. carterii were 
boiled in 100 ml of distilled water for 10 min. Af-
ter cooling to room temperature, it was filtered. 
The aqueous extract (25% w/v) was stored in a 
refrigerator till use (18). On the other hand, the 
aerial parts of C. rotundifolia were collected, 
immediately dried at 45°C, grounded into a 
moderately fine powder (800 g). The aqueous 
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extract (15% w/v) was prepared by adding 150 
g of dried powder to 1000 ml of distilled water 
and heated to about 80°C for 30 min. (26). 
2.3. Induction of DM 
DM was induced in overnight-fasted rats by a 
single intraperitoneal (IP) injection of a freshly 
buffered (0.1 mol/L citrate, pH 4.5) solution of 
STZ at a dosage of 65 mg/kg body weight (b.w.). 
NA (110 mg/kg b.w.) was dissolved in normal 
physiological saline (0.9% NaCl solution) and 
given to counter the hypoglycemic shock 15 
min. before STZ administration. After 72 hours, 
rats with fasting blood glucose levels of >150 
mg/dL were considered diabetic (8). 
2.4. Study design 
The rats were randomly divided into six exper-
imental groups of six rats each as follows: 
Group I (normal control): received IP citrate 
buffer solution (0.5 ml) and oral distilled water 
(0.5 ml) by oral gavage; Group II: (diabetic con-
trol) received IP STZ (65 mg/kg b.w.) and NA 
(110 mg/kg b.w.) (8); Group III: received STZ 
(65 mg/kg b.w.) and NA (110 mg/kg b.w.) and 
thereafter treated with B. carterii water extract 
(100 mg/kg b.w.) (18); Group IV: received STZ 
(65 mg/kg b.w.) and NA (110 mg/kg b.w.) and 
thereafter treated with C. rotundifolia water ex-
tract (100 mg/kg b.w.) (26); Group V: received 
STZ (65 mg/kg b.w.) and NA (110 mg\kg b.w.) 
and thereafter treated with glibenclamide (5 
mg/kg b.w.) (14); Group VI: received STZ (65 
mg/kg b.w.) and NA (110 mg/kg b.w.) and 
thereafter treated with metformin (150 mg/kg 
b.w.) (27). 
Treatment with plant extracts and drugs 
was given daily for 4 weeks using oral gastric 
gavage. Throughout the experimental period, 
starting from the first day of extract administra-
tion to diabetic rats, the body weight and fast-
ing blood glucose level were measured every 7th 
day. On the day 28 of extract administration, 
blood samples were collected from rats by car-
diac puncture under mild ether anesthesia. 
Blood samples were left for 30 min. and centri-
fuged at 3000 rounds per min. for 20 min. to 
separate sera for biochemical analysis. Serum 
glucose, cholesterol and triglycerides were esti-
mated by the enzymatic colorimetric method 
(28). 
2.5. Statistical analysis 
Data were analyzed using the IBM SPSS Statis-
tics version 21.0 (IBM Corp., Armonk, NY, USA). 
All results were expressed as mean ± standard 
error (SE). Means of different groups were com-
pared by one-way analysis of variance (ANOVA) 
test followed by the least significant difference 
(LSD) post hoc test for multiple comparisons. 
Statistical significance was considered at p-
values < 0.05. 
3. Results 
3.1. Effects of plant extracts on body weight 
Table (1) shows that the mean body weights of 
rats in the diabetic control group were lower 
than those in other groups. STZ caused a signifi-
cant weight loss of rats in the diabetic group 
compared to normal controls, whereas treat-
ment of diabetic rats with plant extracts (B. 
carterii or C. rotundifolia) significantly (p<0.05) 
suppressed such a decrease in their mean body 
weights. No significant difference was observed 
in the mean body weight of diabetic rats after 
treatment with metformin compared to those 
treated with C. rotundifolia. On the other hand, 
glibenclamide caused a significant increase in 
the mean body weights of rats compared to the 
groups treated with plant extracts. 
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Table 1. Weekly body weight changes (gm) in rats treated with B. 
carterii and C. rotundifolia water extracts compared to controls 
and drug-treated groups during the experimental period of 28 
days 
Body weight (mean±SE) 
Group  
(n=6 each) 
Day 28 Day 21 Day 14 Day 7 Day 1 
301.00 
±3.00 
 
294.00 
±2.63 
 
286.83 
±2.41 
 
279.33 
±1.54 
 
272.17 
±1.58 
 
Normal control 
246.00 
±1.67* 
 
251.67 
±1.8 * 
 
258.00 
±1.75* 
 
264.83 
±1.40 * 
 
270.33 
±1.31 
 
Diabetic control 
292.33 
±1.43#@$ 
 
287.67 
±1.86#@ 
 
283.50 
±1.18 # 
 
279.00 
±1.51# 
 
272.67 
±0.88 
 
B. carterii  
288.33 
±2.38 #@ 
 
284.83 
±1.87@ 
 
280.83 
±1.85 #@ 
 
276.67 
±2.17 #@ 
 
273.33 
±2.17 
 
C. rotundifolia 
307.00 
±2.48 # 
 
296.50 
±2.47# 
 
288.17 
±2.75# 
 
283.17 
±2.37# 
 
273.50 
±1.54 
 
Glibenclamide  
284.50 
±4.17# 
282.33 
±3.84# 
280.00 
±3.32# 
276.83 
±3.40# 
273.33 
±3.69 
Metformin 
Means with different symbols are significantly different at p<0.05; * signifi-
cant compared to the normal control; #significant compared to the diabetic 
control; @ significant compared to the glibenclamide group; $ significant 
compared to the metformin group 
3.2. Effects of plant extracts on glucose level 
Table (2) shows that rats in the diabetic control 
group showed a significant increase in the 
mean glucose levels from the first week until 
the end of the fourth week of treatment com-
pared to other groups. The mean serum glucose 
levels of the diabetic groups treated with the 
plant extracts were significantly decreased 
compared to the diabetic control group. How-
ever, the decline in the mean glucose levels in 
extract-treated groups was lower than that in 
drug-treated groups.  
3.3. Effects on cholesterol level 
Figure (1) shows that rats in the diabetic con-
trol group had a significant increase in their 
mean cholesterol levels compared to the nor-
mal control group. The rats treated with B. 
carterii extract showed a significant decrease in 
the mean cholesterol level compared to the di-
abetic control group while those treated with C. 
rotundifolia extract showed a non-significant 
decrease in their mean cholesterol levels. On 
the other hand, no significant changes in the 
mean cholesterol levels were observed in rats 
treated with B. carterii and C. rotundifolia com-
pared to those treated with metformin and 
glibenclamide. 
Table 2. Weekly glucose level (mg/dL) changes in rats treated 
with B. carterii and C. rotundifolia water extracts compared to con-
trols and drug-treated groups during the experimental period of 
28 days 
Body glucose level (mean±SE) 
Group 
(n=6 each) 
Day 28 Day 21 Day 14 Day 7 Day 1 
85.67 
±2.76 
88.83 
±1.96 
86.33 
±2.50 
82.17 
±2.20 
83.17 
±2.63 
Normal control 
255.67 
±4.78* 
240.83 
±4.95* 
220.67 
±4.30* 
198.50 
±4.53* 
 
193.00 
±6.18* 
Diabetic control 
125.50 
±5.18#@$ 
 
142.67 
±3.97#@$ 
 
157.67 
±4.59#@$ 
 
171.33 
±5.55#@$ 
 
196.50 
±6.82 
 
B. carterii 
138.50 
±2.85#@$ 
 
150.17 
±3.97#@$ 
 
164.67 
±4.46#@$ 
 
179.17 
±5.27#@$ 
 
203.33 
±4.61 
 
C. rotundifolia 
92.00 
±2.80# 
 
105.67 
±2.20# 
 
126.17 
±2.95# 
 
150.83 
±4.62# 
 
193.00 
±5.62 
 
Glibenclamide  
100.33 
±4.07# 
114.00 
±6.07# 
133.33 
±6.30# 
153.17 
±5.80# 
188.33 
±4.76 
Metformin 
Means with different symbols are significantly different at p<0.05; * signifi-
cant compared to the normal control; # significant compared to the diabetic 
control; @ significant compared to the glibenclamide group; $ significant 
compared to the metformin group 
Figure 1. Effects of Boswellia, Cissus, glibenclamide and metformin on the 
mean cholesterol levels (mg/dL) in STZ/NA-induced diabetic rats; Means 
with different symbols are significantly different at p<0.05; * significant 
compared to the normal control; # significant compared to the diabetic con-
trol; @ significant compared to the glibenclamide group; $ significant com-
pared to the metformin group 
3.4. Effects on level of triglycerides 
Figure (2) shows that rats in the diabetic control 
group had a significant increase in their mean 
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triglycerides levels compared to the normal 
control group. The plant extracts (B. carterii or 
C. rotundifolia) significantly decreased the 
mean triglycerides levels in diabetic rats com-
pared to the diabetic control. However, no sig-
nificant changes were observed in the mean tri-
glycerides levels in rats treated with B. carterii 
compared to those treated with metformin. 
 
Figure 2. Effects of Boswellia, Cissus, glibenclamide and metformin on the 
mean triglycerides levels (mg/dL) in STZ/NA-induced diabetic rats; Means 
with different symbols are significantly different at p < 0.05.; * significant 
compared to the normal control; # significant compared to the diabetic 
control; @ significant compared to the glibenclamide group; $ significant 
compared to the metformin group 
4. Discussion 
DM is a metabolic disorder arising mainly due 
to the poor production of insulin by the pancre-
atic β-cells or their resistance to its action. Hy-
perglycemia in DM leads to serious complica-
tions in vital organs (3). In addition, poorly con-
trolled hyperglycemia leads to the production 
of abnormally high levels of ROS, which could 
react with essential molecules, such as lipids, 
proteins and DNA, leading to histological and 
functional alterations (28, 29).  
Less than 1% of an estimated number of 
250,000 plant species have been screened 
pharmacologically, with only a small fraction of 
these for DM (30). A large proportion of the 
most commonly used drugs in modern medi-
cine, such as atropine, digoxin and some antima-
larials and anticancer drugs, have been derived 
from plant sources (12). In the present study, 
the aqueous extracts of B. carterii resin and C. 
rotundifolia leaves were investigated for their 
hypoglycemic activities in STZ/NA-induced dia-
betic rats.  
STZ induces rapid and irreversible β‐cell ne-
crosis as a result of free radical generation, lead-
ing to a massive reduction in these insulin-
secreting cells (29). Increased levels of ROS in β‐
cells may lead to DNA damage by oxidation, and 
therefore, to their destruction by necrosis (6). 
On the other hand, NA causes activation of the 
poly adenosine diphosphate-ribose synthase to 
repair the damaged DNA (31).  
 In the present study, reduced mean body 
weight in STZ/NA-induced diabetic rats might 
be attributed to the increased muscle wasting 
and degradation of structural proteins due to 
carbohydrate unavailability as an energy source 
(29). This finding agrees with previous observa-
tions that have also reported loss of body weight 
(5, 32). However, a significant increase towards 
normal body weight was observed in diabetic 
rats treated with B. carterii or C. rotundifolia ex-
tracts compared to diabetic controls. This im-
provement indicates the protective effect of 
these extracts against the degradation of struc-
tural proteins and may also be due to their di-
rect lipid lowering activities or their indirect in-
fluence on various lipid regulation systems (33). 
The hypoglycemic activities of plant extracts 
of B. carterii and C. rotundifolia in this study 
could be possibly due to the stimulation of insu-
lin secretion from the remaining β-cells which, 
in turn, promotes tissue glucose utilization in 
diabetic rats either by enhancing its uptake and 
metabolism or by inhibiting hepatic gluconeo-
genesis (28). Moreover, the anti-oxidant activity 
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of B. carterii and C. rotundifolia may be one of 
the possible actions of their hypoglycemic activ-
ity. The antioxidant effects of different Boswel-
lia and Cissus species have been reported by 
several researchers (27, 34). The hypoglycemic 
activity of B. carterii could be partly attributed 
to the presence of pentacyclic triterpene (bos-
wellic acid derivatives) (35). In addition, the 
presence of triterpenes, glycosides, flavonoids, 
coumarins or saponins could be responsible for 
the hypoglycemic activity of C. rotundifolia (24). 
Being comparable to those of commonly mar-
keted drugs used for treating type-2 DM, the 
anti-hyperglycemic effects of B. carterii and C. 
rotundifolia extracts in diabetic rats provide a 
pharmacological evidence for their folklore 
claim as anti-diabetic agents (18, 22, 33). 
Hyperlipidemia in diabetic patients repre-
sents a risk factor for coronary heart diseases. 
The abnormally high levels of serum lipids are 
mainly due to the action of insulin that inhibits 
the actions of lipolytic hormones on the fat de-
pots (28). Normally, insulin activates lipopro-
tein lipase, which hydrolyzes triglycerides. 
However, in DM, lipoprotein lipase is not acti-
vated as a result of insulin deficiency, resulting 
in hypertriglyceridemia and hypercholesterol-
emia (36). 
In the present study, the altered serum lipid 
profile was disturbed in diabetic rats by the 
significant increase in cholesterol and triglycer-
ides levels compared to normal controls. 
Treatment of diabetic rats with B. carterii and C. 
rotundifolia extracts significantly corrected the 
levels of cholesterol and triglycerides towards 
normal. This improvement may be partly at-
tributed to the increase in insulin secretion that 
affects lipid metabolism and to the regeneration 
of β‐cell as a result of the decrease in produc-
tion of free radicals by lipid peroxidation (4, 
37). Thus, the two plant extracts could be help-
ful in improving lipid metabolism that may, in 
turn, help to prevent diabetic complications 
such as coronary heart diseases and atheroscle-
rosis (38). The present study revealed a similari-
ty in the reduction of cholesterol levels between 
B. carterii and metformin from one side as well 
as between C. rotundifolia and glibenclamide 
from the other side. This may reflect the compa-
rable actions of the plant extracts and the tested 
drugs (18, 22, 36). 
The findings of the present study are in 
agreement with other previous studies, which 
reported that treatment with B. carterii led to a 
significant improvement in the decreased body 
weight, hyperglycemia, hypoinsulinemia, de-
creased liver glycogen caused by alloxan (18). 
Moreover, other studies on other Boswellia spe-
cies reported the antiglycation and anti-oxidant 
activities of B. sacra, B. serrata and B. glabra in 
experimental diabetic rats (34, 39). In addition, 
the hypoglycemic activity of C. rotundifolia in the 
present study is in correlation with the findings 
by Onyechi et al. (1998) on healthy human sub-
jects and Shukery (2012) on male rabbits (23, 
40). Moreover, the anti-inflammatory and anti-
oxidant activities of C. rotundifolia have been re-
cently reported (24). Other studies reported the 
hypoglycemic and hypolipidemic activities of 
other species of the same genus Cissus, including 
C. verticillata and C. quadragualis (41, 42), sup-
porting the hypoglycemic activity of C. rotundifo-
lia in the present study.  
5. Conclusions 
Water extracts of B. carterii and C. rotundifolia 
are efficacious in lowering blood glucose in dia-
betes rats in a way resembling the actions of 
common anti-hyperglycemic drugs (glibencl-
amide and metformin). They also have anti-
hyperlipidemic and anti-oxidant properties. 
Studies on standardization, characterization, ef-
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ficacy, long-term side effects, toxicity and plant-
drug interaction are recommended.  
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